Publication | Closed Access
RSV Policy Statement —Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. <i>Pediatrics</i> 2014;134(2):415–420
50
Citations
0
References
2014
Year
Respiratory Virus ImmunityRsv Policy StatementPediatric EpidemiologyRespiratory ComplicationsPediatricsRespiratory InfectionPediatric Lung DiseaseInfectious Respiratory DiseaseYoung ChildrenPalivizumab ProphylaxisInfection ControlMedicineHospital Medicine
No additional data available for this publication yet. Check back later!